Effects of plasma and serum on the in vitro expression of bovine leukemia virus
- PMID: 8397323
Effects of plasma and serum on the in vitro expression of bovine leukemia virus
Abstract
Background: Bovine leukemia virus (BLV) is difficult to detect in freshly isolated peripheral blood mononuclear cells (PBMCs) from infected cattle. The lack of viral expression has been attributed to a plasma blocking factor capable of inhibiting the in vitro expression of the BLV p24 antigen.
Experimental design: The purpose of this study was to investigate the effects of plasma and serum on the in vitro synthesis of the p24 antigen within short-term cultures of PBMCs from BLV-seropositive cows. BLV p24 antigen was detected in the cell lysate using an antigen capture enzyme-linked immunosorbent assay.
Results: Antigen synthesis was suppressed in PBMCs cultured in plasma from both seropositive and seronegative cows. Serum from infected cows suppressed p24 expression, but to a lesser extent than any of the plasmas. Addition of phytohemagglutinin-P to the cultures resulted in the detection of more p24 in PBMCs cultured in serum, but had no effect on p24 expression within cells cultured in plasma. The reduction in p24 was not related to lower cell viability, nor was it influenced by the effects of the anticoagulant citrate-phosphate dextrose on calcium-dependent lymphocyte activation. No significant difference was observed in the potency of the p24 inhibition between cells grown in autologous and homologous serum, or between cells grown in autologous and homologous plasma from seropositive cows.
Conclusions: Blocking activity is present in the plasma of seronegative cows, and in the plasma and serum of BLV-seropositive cows. This activity may be important in regulating viral latency and provirus expression in vivo.
Similar articles
-
Purified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture.Can J Vet Res. 2005 Jul;69(3):186-92. Can J Vet Res. 2005. PMID: 16187548 Free PMC article.
-
Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line.Vet Immunol Immunopathol. 2009 Oct 15;131(3-4):246-58. doi: 10.1016/j.vetimm.2009.04.017. Epub 2009 May 4. Vet Immunol Immunopathol. 2009. PMID: 19497626
-
Evidence for bovine leukemia virus in mammary epithelial cells of infected cows.Lab Invest. 1994 Sep;71(3):359-65. Lab Invest. 1994. PMID: 7933986
-
Effect of infection with bovine leukosis virus on lymphocyte proliferation and apoptosis in dairy cattle.Am J Vet Res. 2011 Aug;72(8):1059-64. doi: 10.2460/ajvr.72.8.1059. Am J Vet Res. 2011. PMID: 21801063
-
Evidence for bovine leukemia virus infection of peripheral blood monocytes and limited antigen expression in bovine lymphoid tissue.Lab Invest. 1992 May;66(5):608-17. Lab Invest. 1992. PMID: 1315405
Cited by
-
Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkappaB element in the long terminal repeat.Can J Vet Res. 2007 Apr;71(2):119-28. Can J Vet Res. 2007. PMID: 17479775 Free PMC article.
-
Purified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture.Can J Vet Res. 2005 Jul;69(3):186-92. Can J Vet Res. 2005. PMID: 16187548 Free PMC article.
-
In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.J Virol. 1998 Jul;72(7):5994-6003. doi: 10.1128/JVI.72.7.5994-6003.1998. J Virol. 1998. PMID: 9621062 Free PMC article.
-
Isolation of a bovine plasma fibronectin-containing complex which inhibits the expression of bovine leukemia virus p24.J Virol. 2005 Jul;79(13):8164-70. doi: 10.1128/JVI.79.13.8164-8170.2005. J Virol. 2005. PMID: 15956561 Free PMC article.